Journal article

Glucose as an agent of post-translational modification in diabetes - New cardiac epigenetic insights

Kimberley M Mellor, Margaret A Brimble, Lea MD Delbridge

Life Sciences | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2015

DOI: 10.1016/j.lfs.2014.03.020

Citation metrics

17Web of Science
4Scopus
16Scopus

Keywords

Glycation End-Products
Cardiomyocyte
Cell-Death
Models, Cardiovascular
Heart-Failure
Linked N-Acetylglucosamine
Diastolic Dysfunction
Glycation End Products, Advanced
Protein Processing, Post-Translational
Cardiomyocytes
Cardiovascular-Disease
Science & Technology
Glycation
Protein O-Glcnacylation
Cardiomyopathy
Humans
Diabetes
O-Glcnacylation
Advanced Glycation Endproducts
Pharmacology & Pharmacy
Epigenesis, Genetic
Glycosylation
Heart
Life Sciences & Biomedicine
Diabetes Mellitus
Medicine, Research & Experimental
Insulin Resistance
Glycosylation End Products, Advanced
Signal Transduction
Glucose
Insulin-Resistance
Research & Experimental Medicine